Technical Analysis for BEAM - Beam Therapeutics Inc.

Grade Last Price % Change Price Change
D 66.2 3.24% 2.08
BEAM closed up 3.24 percent on Tuesday, May 11, 2021, on 2.25 times normal volume. It was able to bounce off of its 200 day moving average, an important long-term support line.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Down
Historical BEAM trend table...

Date Alert Name Type % Chg
Slingshot Bearish Bearish Swing Setup 0.00%
200 DMA Support Bullish 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Wide Range Bar Range Expansion 0.00%
Multiple of Ten Bearish Other 0.00%
Multiple of Ten Bullish Other 0.00%
Outside Day Range Expansion 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Stochastic Reached Oversold Weakness 3.24%
Multiple of Ten Bearish Other 3.24%
Older End-of-Day Signals for BEAM ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Possible Pocket Pivot about 13 hours ago
Rose Above Previous Day's High about 13 hours ago
Outside Day about 13 hours ago
Up 10% about 13 hours ago
Up 1 ATR about 13 hours ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Beam Therapeutics Inc., a biotechnology company, engages in developing precision genetic medicines for patients suffering from serious diseases in the United States. It is developing therapies for the development of sickle cell disease and beta-thalassemia; CAR-T cell therapies for pediatric T-cell acute lymphoblastic leukemia and pediatric acute myeloid leukemia; therapies for alpha-1 antitrypsin deficiency and glycogen storage disorder 1A; and therapies for ocular and central nervous system disorders. The company was founded in 2017 and is based in Cambridge, Massachusetts.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cancer Gene Therapy Acute Myeloid Leukemia Nervous System Disorders Central Nervous System Disorders Leukemia Serious Diseases Acute Lymphoblastic Leukemia Antitrypsin Deficiency Sickle Cell Disease Thalassemia Acute Leukemia Beta Thalassemia Glycogen Storage Disorder

Is BEAM a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 126.9
52 Week Low 18.76
Average Volume 1,016,983
200-Day Moving Average 60.96
50-Day Moving Average 79.41
20-Day Moving Average 74.41
10-Day Moving Average 73.43
Average True Range 6.77
ADX 16.09
+DI 16.01
-DI 35.85
Chandelier Exit (Long, 3 ATRs ) 64.02
Chandelier Exit (Short, 3 ATRs ) 76.66
Upper Bollinger Band 84.22
Lower Bollinger Band 64.60
Percent B (%b) 0.08
BandWidth 26.37
MACD Line -3.13
MACD Signal Line -2.25
MACD Histogram -0.8763
Fundamentals Value
Market Cap 3.84 Billion
Num Shares 58 Million
EPS -2.01
Price-to-Earnings (P/E) Ratio -32.96
Price-to-Sales 115294.55
Price-to-Book 15.89
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 88.21
Resistance 3 (R3) 87.37 79.19 84.54
Resistance 2 (R2) 79.19 73.59 79.61 83.31
Resistance 1 (R1) 72.70 70.13 75.95 73.54 82.09
Pivot Point 64.52 64.52 66.15 64.94 64.52
Support 1 (S1) 58.03 58.92 61.28 58.87 50.31
Support 2 (S2) 49.85 55.46 50.27 49.09
Support 3 (S3) 43.36 49.85 47.86
Support 4 (S4) 44.20